Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: HBsAg confirmatory testing is crucial for accurately diagnosing HBV infection and avoiding false positives. We compared the performance of human-derived and sheep-derived anti-HBs reagents in the Elecsys HBsAg confirmatory test (Roche Diagnostics, Germany).
Methods: Samples with a HBsAg COI of 0.9 or more underwent confirmatory testing with both reagents. Results showed a high overall agreement rate of 98% between human and sheep reagents.
Results: The average confirmation percentage with sheep anti-HBs was significantly lower than with human anti-HBs (6.9% vs. 20.0%, p = 0.002). Additionally, some strongly positive HBsAg samples could not be neutralized.
Conclusions: This suggests that the polyclonal antibodies in these reagents have different specificities and affinities for HBsAg epitopes. The findings emphasize the importance of reagent specificity and affinity to ensure accurate HBV diagnosis. Additional HBV markers and clinical context must be considered to confirm the diagnosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.7754/Clin.Lab.2024.240527 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Hepatitis B and C landscape in Uzbekistan: epidemiological patterns revealed in a study of 1 040 000 people.
Eur J Public Health
August 2025
Department of Hepatology, Research Institute of Virology, Tashkent, Uzbekistan.
Uzbekistan initiated a nationwide screening program for viral hepatitis B (HBV) and C (HCV) in response to the global call for viral hepatitis elimination by 2030. This study aimed to assess HBV and HCV prevalence among the general population, provide treatment for diagnosed cases, and evaluate the effectiveness of direct-acting antiviral (DAA) therapy for HCV. From July 2022 to June 2024, 1 048 575 individuals aged 1-95 years were screened at local healthcare facilities using rapid immunochromatographic tests for hepatitis B surface antigen (HBsAg) and antibodies against hepatitis C virus (anti-HCV).
View Article and Find Full Text PDFBackground: Hepatitis B surface antigen (HBsAg) is an early and sensitive serum marker of infectivity for the detection of hepatitis B virus (HBV) infection. The availability of sensitive methods for its detection can generate false-positive results, requiring a confirmatory test that is both costly and unavailable in all medical laboratories. The objective of the study was to determine, using the two automated systems (Architect and Alinity i (Abbott)), a cutoff value at which HBsAg is considered positive without the need for a confirmatory test and to assess the role of anti-HBc antibodies as an indirect marker of qualitative HBsAg confirmation.
View Article and Find Full Text PDFResolving Uncertainty in Hepatitis B Diagnosis: Evaluating Neutralization Testing for Borderline HBsAg.
Ann Clin Lab Sci
May 2025
Department of Laboratory Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea
Objective: To assess the performance of neutralization confirmatory testing for borderline hepatitis B surface antigen (HBsAg) results (signal-to-cutoff [S/CO] 1.0-10.0) in a low-prevalence population.
View Article and Find Full Text PDFPerformance and acceptability of pre-donation screening and post-donation testing for hepatitis B infection in a resource-limited blood service.
Vox Sang
August 2025
Etablissement Français du Sang, Marseille, France.
Background And Objectives: Hepatitis B virus (HBV) is the virus transmissible by transfusion in Cameroon with highest prevalence. The benefit of pre-donation screening (PDS) versus post-donation testing (PDT) remains to be confirmed because of controversial results produced by the use of different methodologies. This study aims to compare the performance and blood donor acceptability with PDT strategy in the reduction of HBV risk.
View Article and Find Full Text PDFPrevalence of hepatitis B infection and its associated factors in rural South India.
Indian J Gastroenterol
August 2025
Department of Medical Gastroenterology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, 605 006, India.
Background: Information on the burden of hepatitis B infection is required for targeted interventions and streamlining the diagnosis and treatment facilities across various healthcare levels in India. Therefore, this study was aimed at determining the prevalence of hepatitis B infection and associated factors among the adult population in a rural area of South India.
Methods: A community-based cross-sectional study was conducted among the rural adult population aged 18 years and above between January 2021 and April 2022.